| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA1018214 | F | Cytotoxicity against mouse doxorubicin-sensitive P388 cells after 3 days | Mus musculus | 11 | cell-based format | Scientific Literature | ||
| 2. | ALA1018215 | F | Cytotoxicity against mouse doxorubicin-resistant P388 cells after 3 days | Mus musculus | 11 | cell-based format | Scientific Literature | ||
| 3. | ALA1018216 | F | Antitumor activity in mouse M5076 cells xenografted in BDF1 mouse at 0.31 mg/kg, ip administered from day 1 to 9 after transplantation | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 4. | ALA1018217 | F | Antitumor activity in mouse M5076 cells xenografted in BDF1 mouse at 0.63 mg/kg, ip administered from day 1 to 9 after transplantation | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 5. | ALA1018218 | F | Antitumor activity in mouse M5076 cells xenografted in BDF1 mouse at 1.25 mg/kg, ip administered from day 1 to 9 after transplantation | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 6. | ALA1018219 | F | Antitumor activity in mouse M5076 cells xenografted in BDF1 mouse at 2.50 mg/kg, ip administered from day 1 to 9 after transplantation | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 7. | ALA1018220 | F | Antitumor activity in mouse M5076 cells xenografted in BDF1 mouse at 5 mg/kg, ip administered from day 1 to 9 after transplantation | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 8. | ALA1018221 | T | Toxicity in mouse M5076 cells xenografted in BDF1 mouse at 10 mg/kg, ip administered from day 1 to 9 after transplantation | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 9. | ALA1018222 | F | Antitumor activity in mouse B16 cells xenografted in BDF1 mouse at 0.62 mg/kg, ip administered from day 1 to 5 after transplantation | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 10. | ALA1018223 | F | Antitumor activity in mouse B16 cells xenografted in BDF1 mouse at 1.25 mg/kg, ip administered from day 1 to 5 after transplantation | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 11. | ALA1018224 | F | Antitumor activity in mouse B16 cells xenografted in BDF1 mouse at 2.50 mg/kg, ip administered from day 1 to 5 after transplantation | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 12. | ALA1019017 | F | Antitumor activity in mouse B16 cells xenografted in BDF1 mouse at 5 mg/kg, ip administered from day 1 to 5 after transplantation | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 13. | ALA1006924 | T | Toxicity in mouse B16 cells xenografted in BDF1 mouse at 10 mg/kg, ip administered from day 1 to 5 after transplantation | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 14. | ALA1006925 | F | Cytotoxicity against human 9KB cells after 3 days | Homo sapiens | 11 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!